<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05028491</url>
  </required_header>
  <id_info>
    <org_study_id>hf-meibomian glands</org_study_id>
    <nct_id>NCT05028491</nct_id>
  </id_info>
  <brief_title>The Influence of Meibomian Gland Expression on Corneal Aberrations in MGD Patients</brief_title>
  <official_title>The Effect of Meibomian Gland Thermal Massage on Corneal Aberrations in Meibomian Gland Dysfunction Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the influence of corneal-aberrations before and after the meibomian gland thermal&#xD;
      massage treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      62 MGD patients treated with meibomian gland thermal massage once a week for 3 to 4 weeks&#xD;
      were recruited.The Ocular Surface Disease Index questionnaire; tear film assessment&#xD;
      encompassing tear meniscus height and non-invasive keratograph breakup time ; meibography&#xD;
      score,corneal fluorescein staining; the Schirmer I test ; expressible meibomian gland, and&#xD;
      quality ,anterior and total corneal aberrations were evaluated before and after treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Actual">July 29, 2021</completion_date>
  <primary_completion_date type="Actual">June 29, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>corneal aberration corneal aberrations</measure>
    <time_frame>baseline and 1 week after treatment</time_frame>
    <description>Corneal aberrations were measured with a Pentacam。 The anterior corneal wavefront aberration was expanded with normalized Zernike polynomials.The corneal aberration from 3rd to 6th order were recorded as the root mean square (RMS) for analysis.</description>
  </primary_outcome>
  <enrollment type="Actual">62</enrollment>
  <condition>Meibomian Gland Dysfunction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Diagnosed as meibomian glands dysfunction in our hospital; treatment with thermal massage&#xD;
        and expression&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  tear break-up time (BUT) ≤10 seconds or Schirmer I test (SIT) ≤10 mm, the presence of&#xD;
             dry eye symptoms, and fluorescein staining (FL) score &lt;3 points and at least one lid&#xD;
             margin abnormality and poor meibomian gland expressibility&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  eyelid structure abnormal(Entropion , ectropion);&#xD;
&#xD;
          -  having received any other treatment for MGD within three months&#xD;
&#xD;
          -  history of ocular surgery&#xD;
&#xD;
          -  contact lens use&#xD;
&#xD;
          -  ocular infection&#xD;
&#xD;
          -  any type of corneal scarring&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yune Zhao</last_name>
    <role>Study Director</role>
    <affiliation>Ophthalmology and Optometry Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eye Hospital of Wenzhou Medical College</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325027</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 25, 2021</study_first_submitted>
  <study_first_submitted_qc>August 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>Yune Zhao</investigator_full_name>
    <investigator_title>Vice president of Eye Hospital of Wenzhou Medical University</investigator_title>
  </responsible_party>
  <keyword>thermal massage</keyword>
  <keyword>corneal aberrations</keyword>
  <keyword>physical therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meibomian Gland Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

